We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

32 hedge funds and large institutions have $267M invested in Myovant Sciences Ltd. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

11% less funds holding

Funds holding: 36 → 32 (-4)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

57% less capital invested

Capital invested by funds: $628M → $267M (-$360M)

Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.73%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
7
Increased
12
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.58M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$2.23M
3
PIM
Platinum Investment Management
Australia
+$825K
4
EU
Emory University
Georgia
+$685K
5
Millennium Management
Millennium Management
New York
+$572K

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$471M
2
TCM
Tekla Capital Management
Massachusetts
-$3.8M
3
GPP
Great Point Partners
Connecticut
-$2.03M
4
AAP
Ardsley Advisory Partners
Connecticut
-$1.27M
5
SCM
Sio Capital Management
New York
-$923K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$33K +$12.8K +841 +122%
Deutsche Bank
27
Deutsche Bank
Germany
$26K +$18.8K +1,235 +4,574%
UBS Group
28
UBS Group
Switzerland
$22K +$15.6K +1,025 New
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$2.13K +$1.29K +85 +567%
MAM
30
Meeder Asset Management
Ohio
$2K – – –
ML
31
McAdam LLC
Pennsylvania
$1K +$533 +35 New
QF
32
QVT Financial
New York
– -$471M -37,231,342 Closed
GPP
33
Great Point Partners
Connecticut
– -$2.03M -160,530 Closed
AAP
34
Ardsley Advisory Partners
Connecticut
– -$1.27M -100,000 Closed
SCM
35
Sio Capital Management
New York
– -$923K -73,054 Closed
SI
36
SCP Investment
California
– -$253K -20,000 Closed
OAM
37
Oxford Asset Management
United Kingdom
– -$175K -13,774 Closed
TRCT
38
Tower Research Capital (TRC)
New York
– -$60K -4,741 Closed
TA
39
Teachers Advisors
New York
– -$9K -730 Closed
PO
40
Private Ocean
California
– -$9K -700 Closed
Macquarie Group
41
Macquarie Group
Australia
– -$8K -600 Closed
Citigroup
42
Citigroup
New York
– -$1K -41 Closed
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– +$15 +1 +50%
1
2

MYOV Hedge Fund Activity: Q1 2018 in Review

32 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2018, worth a combined $267M — down 57% from $628M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MYOV and 7 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 12 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $6.58M. The largest seller was QVT Financial, exiting entirely with an estimated $471M sold.

  • 32 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2018, down from 36 in Q4 2017.
  • Funds reported $267M of Myovant Sciences Ltd. stock for Q1 2018, down 57% quarter-over-quarter.
  • 7 funds opened new Myovant Sciences Ltd. positions in Q1 2018 and 11 closed out, a net change of -4 holders.
  • The largest Myovant Sciences Ltd. buyer in Q1 2018 was T. Rowe Price Associates, an estimated $6.58M added.
  • The largest Myovant Sciences Ltd. seller in Q1 2018 was QVT Financial, an estimated $471M sold.

Based on aggregated 13F filings for Q1 2018.